ENTX financials
Entera Bio (ENTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- ENTX revenue was $42.00K in fiscal 2025, net income -$11.44M.
ENTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $42.00K | $0.00 | -$11.53M | -$11.44M | 0.25 |
| 2024 | $181.00K | $9.00K | -$9.59M | -$9.54M | 0.25 |
| 2023 | $0.00 | $0.00 | -$8.89M | -$8.89M | 0.31 |
| 2022 | $134.00K | $33.00K | -$13.02M | -$13.07M | 0.45 |
| 2021 | $571.00K | $198.00K | -$12.22M | -$12.19M | 0.47 |
| 2020 | $365.00K | $65.00K | -$11.17M | -$11.22M | 0.67 |